Clinical Trials
53 trialsStem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers
National Institutes of Health Clinical Center (CC)
ROBDOG
Koç University
E-STOP2
Hospital Universitari Vall d'Hebron Research Institute
HematoCare
Azienda USL Reggio Emilia - IRCCS
COMPLHEMATO
University Hospital, Limoges
Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis
Nanfang Hospital, Southern Medical University
A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological Malignancies
Kousai Bio Co., Ltd.
Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT
University of Arizona
Safety and Efficacy of DIT101 in Relapsed or Refractory Hematologic Malignancies
Tcelltech Inc.
The Efficacy and Safety of Stereotactic Radiotherapy Bridging Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignance Patients With Extramedullary Infiltrating
Institute of Hematology & Blood Diseases Hospital, China
Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies
M.D. Anderson Cancer Center
CALySSEY
Baylor College of Medicine
The Safety and Efficacy of the Regimen of Thiotepa + Fludarabine +Granulocyte Colony-Stimulating Factor+ Cytarabine + Busulfan in Single Unrelated Umbilical Cord Blood Transplantation
Institute of Hematology & Blood Diseases Hospital, China
DETERMINE
Cancer Research UK
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
Ascentage Pharma Group Inc.
Assessing DCog Short for Neurotoxicity in CAR-T
Beth Israel Deaconess Medical Center
CARE-RT
Jinnah Postgraduate Medical Centre
Exploratory Study on in Vivo CAR-T Therapy Targeting CD20 for the Treatment of Hematological Malignancies
The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army
Exploratory Study on the Treatment of Recurrent and Refractory Hematological Malignancies With WGb-0302 Injection
Sichuan University
Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation
Massachusetts General Hospital
A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies
Affiliated Hospital of Jiangsu University
A Phase I Trial of QLS2313 Injection in Relapsed/Refractory Hematological Malignancies
Qilu Pharmaceutical Co., Ltd.
CASEY
Baylor College of Medicine
PEPOH
University of Salamanca
PREHAB-HSCT
Hospital del Salvador
HAPLO2022
Miltenyi Biomedicine GmbH
A Study of BL-M24D1 in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies
Sichuan Baili Pharmaceutical Co., Ltd.
MAHATMAt
Assistance Publique Hopitaux De Marseille
A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies
Biotroy Therapeutics
The Effect of a Protective Oral Care Protocol Using Peppermint Oil Mouthwash
Ankara University
Virtual Reality Intervention for Symptom Management in Stem Cell Transplantation
Halic University
A Clinical Study to Evaluate the Safety and Efficacy of Anti-human CD 7 CAR-NK Cell Injection in Subjects With Relapsed and Refractory CD7-positive Hematological Malignancy
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
TARGETALLO
Centre Hospitalier Universitaire de Nice
Prospective Study Evaluate the Timing of Empirical Treatment for Carbapenem-resistant Bacterials (CROEAT Study)
Shanghai Jiao Tong University School of Medicine
UNIVERSAL GENETIC TESTING OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES (UGT)
Augusta University
Early Clinical Study of JY306 Universal NK Cell Injection in the Treatment of Adult Relapsed or Refractory CD70+ Malignant Hematologic Tumors
The First Affiliated Hospital with Nanjing Medical University
Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Hematological Cancer
Ciusss de L'Est de l'Île de Montréal
Antibiotic Stewardship in Suspected Neutropenic Fever (ASTERIC Trial)
The University of Hong Kong
A Study of the Effect of Laughter Therapy on the Mental Health and Quality of Survival of Hematopoietic Stem Cell Transplant Patients
Institute of Hematology & Blood Diseases Hospital, China
VORIPRECI
University Hospital, Grenoble
Safety, Tolerability and Preliminary Efficacy of Erythrocyte-αPD-1 Conjugate in Patients With Advanced Malignancies
Zhejiang Provincial People's Hospital
Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic Diseases
Anhui Provincial Hospital
Anti-GPRC5D CAR-T Cells (CT071) in Participants With RRMM or RRpPCL
CARsgen Therapeutics Co., Ltd.
END
Brigham and Women's Hospital
Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 Blockade
Beijing 302 Hospital
ILDTreg2
Assistance Publique - Hôpitaux de Paris
A Clinical Trial of TQB3909 Tablets Combined With TQB3702 Tablets in Patients With Hematologic Malignancy
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
IRAF-ISCM
University Hospital, Caen
Collection of Sequential Samples From Patients With Malignant Myeloid Hemopathy for the Study of Treatment Resistance
Institut Paoli-Calmettes
KCAT19
University College, London